Area of Focus - Thendor Therapeutics

Developing new treatments to address harmful scarring in the lungs and help preserve breathing function.

Through our subsidiary Thenduro, advancing therapies for fibrotic conditions of the urinary system, where current treatments remain limited.

Targeting shared biological pathways that drive fibrosis across multiple organs.